Cancer Control Agency Chief Executive Rami Rahal to Retire Mid-Term

The chief executive of the Cancer Control Agency, Rami Rahal, has announced his intention to retire in December 2023, stepping down midway through his five-year term. In a statement released by the agency, Rahal indicated that he has made this decision to spend more time with his family in Canada.

Rahal took the helm of the Cancer Control Agency in July 2023, shortly after its establishment in December 2019. The agency was created to ensure that every cancer patient in New Zealand receives “world-class cancer care, no matter who they are or where they live,” a vision articulated by former Prime Minister Jacinda Ardern at the time.

Achievements Under Rahal’s Leadership

During his tenure, Rahal has been recognized for providing strong leadership. The agency’s statement highlighted his dedication to advancing the key priorities outlined in the New Zealand Cancer Action Plan. Under his guidance, the Cancer Control Agency has strengthened collaboration across the health system and championed initiatives aimed at improving cancer care and outcomes for all New Zealanders.

“Rami has provided strong and steady leadership, guiding New Zealand’s cancer control efforts with dedication and clarity,” the statement read. His efforts have been instrumental in fostering a holistic approach to cancer care, ensuring that patients receive the necessary support and treatment regardless of their circumstances.

Before joining the Cancer Control Agency, Rahal spent over a decade with the Canadian Partnership Against Cancer, where he served as vice president. His extensive experience in cancer control and public health has been a significant asset to the agency.

Future of the Cancer Control Agency

As Rahal prepares to step down, the agency faces the challenge of continuing its mission without his leadership. His departure comes at a critical time when the agency is working to implement various initiatives aimed at enhancing cancer care services throughout New Zealand. The ongoing collaboration with healthcare providers and stakeholders will be crucial in maintaining momentum in the fight against cancer.

The Cancer Control Agency, since its inception, has aimed to transform cancer care in New Zealand. As the organization looks for Rahal’s successor, the focus will remain on ensuring that every individual facing a cancer diagnosis receives equitable and effective treatment.

Rahal’s retirement marks the end of a significant chapter for the Cancer Control Agency, but his contributions have laid a solid foundation for future leadership and ongoing efforts in cancer care reform.